PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway

Xiu Wang; Wanxing Duan; Xuqi Li; Jiangbo Liu; Donghong Li; Lianhong Ye; Lu Qian; Aijun Yang; Qinhong Xu; Han Liu; Qiaoshan Fu; Erxi Wu; Qingyong Ma; Xin Shen

doi:10.18632/oncotarget.5726

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway

Xiu Wang _, Wanxing Duan, Xuqi Li, Jiangbo Liu, Donghong Li, Lianhong Ye, Lu Qian, Aijun Yang, Qinhong Xu, Han Liu, Qiaoshan Fu, Erxi Wu, Qingyong Ma and Xin Shen

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:40959-40969. https://doi.org/10.18632/oncotarget.5726

Metrics: PDF 1765 views | HTML 1915 views | ?

Abstract

Xiu Wang1,2, Wanxing Duan1, Xuqi Li1, Jiangbo Liu1, Donghong Li2, Lianhong Ye2, Lu Qian2, Aijun Yang2, Qinhong Xu1, Han Liu1, Qiaoshan Fu2, Erxi Wu3, Qingyong Ma1, Xin Shen4

1Department of Hepatobiliary Surgery, First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an, 710061, China

2Department of Gynecology and Obstetrics, Affiliated Guangren Hospital of Xi’an Jiaotong University, Xi’an, 710004, China

3Department of Neurosurgery, Baylor Scott & White Health, Temple, Texas, 76502, USA

4Department of Anesthesiology, First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an, 710061, China

Correspondence to:

Qingyong Ma, e-mail: [email protected]

Xin Shen, e-mail: [email protected]

Keywords: human pituitary tumor-transforming gene (PTTG), metabolic switch, ovarian cancer, aerobic glycolysis, oxidative phosphorylation

Received: April 04, 2015 Accepted: October 14, 2015 Published: October 26, 2015

ABSTRACT

Human pituitary tumor-transforming gene (PTTG) is a proto-oncogene involved in the development, invasion, and metastasis of many types of cancer, including ovarian cancer. However, little is known about the role of PTTG in the metabolic shift of ovarian cancer cells. In our study, we show that PTTG expression was positively correlated with the differentiation degree of ovarian cancer tissue. In addition, PTTG suppression by specific shRNA could inhibit the proliferation of ovarian cancer cells A2780 and SKOV-3. Furthermore, aerobic glycolysis was suppressed and oxidative phosphorylation was increased in ovarian cancer cells after PTTG suppression. We further found that the expression of c-myc and several crucial enzymes involved in aerobic glycolysis (e.g., PKM2, LDHA, and glucose transporter 1 (GLUT-1)) were downregulated by PTTG knockwown. Overexpression of c-myc could prevent the metabolic shift induced by PTTG knockwown. Together, our findings suggest that the oncogene PTTG promotes the progression of ovarian cancer cells, and its loss resists tumor development, in part, by regulating cellular metabolic reprogramming that supports cell growth and proliferation via c-myc pathway.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5726

Publication Alerts

Research Papers:

PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway

Abstract